Cargando…
miR-22-3p/PGC1β Suppresses Breast Cancer Cell Tumorigenesis via PPARγ
In this study, we found that miR-22-3p expression was decreased in breast cancer (BC) cell lines and tissues. Overexpression of miR-22-3p inhibited the proliferation and migration of BC cells in vitro and in vivo, while depletion of miR-22-3p exhibited the opposite effect. Importantly, miR-22-3p cou...
Autores principales: | Wang, Xuehui, Yao, Zhilu, Fang, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981180/ https://www.ncbi.nlm.nih.gov/pubmed/33777130 http://dx.doi.org/10.1155/2021/6661828 |
Ejemplares similares
-
miR-22 in tumorigenesis
por: Song, Su Jung, et al.
Publicado: (2014) -
MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα
por: Yin, Zhongwei, et al.
Publicado: (2019) -
Proanthocyanidin Alleviates Liver Ischemia/Reperfusion Injury by Suppressing Autophagy and Apoptosis via the PPARα/PGC1α Signaling Pathway
por: Yao, Zhilu, et al.
Publicado: (2023) -
Angiotensin II-induced muscle atrophy via PPARγ suppression is mediated by miR-29b
por: Li, Jin, et al.
Publicado: (2020) -
PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s
por: Corona, Juan Carlos, et al.
Publicado: (2014)